Path to Progress Raises $1 Million

Printer Friendly

Path to Progress Raises $1 Million

May 20, 2011

CHICAGO, IL - Last weekend’s blustering winds and temperatures more like March than mid May didn’t dampen the spirits of the thousands of dedicated supporters at the American Brain Tumor Association's 6th Annual Path to Progress 5K at Soldier Field. The event generated more than $1 million for the ABTA’s research and patient-family programs, making this year’s effort the most successful in the event’s six year history.

The Path to Progress 5K Run/Walk began in 2006 as a way to raise brain tumor awareness, while supporting ABTA programs. The event has grown nearly every year – moving from the Montrose Harbor area to Soldier Field in 2008 – and today, is ABTA’s signature fundraising event.

“For many participants, their Path to Progress began last November with calls to family, friends and colleagues to support them at the spring fundraiser,” said ABTA Executive Director Elizabeth Wilson. “By Friday, one day before the event, donations had surpassed last year's event total by more than $30,000. Donations on Saturday were at nearly $980,000, and early this week had firmly reached $1 million.”
This 2011 Path to Progress 5K run kicked-off at 7:30 a.m. with nearly 1,500 runners. The male winner was Keith Mulhollon, of Chicago, with a time of 15:48; the female winner was Meghan Braffet, also of Chicago, finishing at 18:08.

The event included more than 300 teams of runners and walkers, hailing from 35 states, and ranging in age from 1 to 85. They included brain tumor survivors, family members, friends and supporters.
The lead fundraising team was the 160-member Team WILLPOWER from Glenview, Ill. The team consisted of the friends and family of William “Will” Hicks. Hicks was diagnosed with a malignant brain tumor in January 2010, and passed away 10 months later at the age of 26. To date, Team WILL POWER has raised nearly $45,000.

“This level of support will allow us to continue and expand our critical funding of brain tumor research and the delivery of desperately needed resources and support to patients and families living with this disease.”


Founded in 1973, the American Brain Tumor Association was the first non-profit organization dedicated to funding brain tumor research. Today, the ABTA is a catalyst for research-based breakthroughs in the causes, diagnosis and treatment of brain tumors, and recognized as the leading resource in patient-centered brain tumor information, education and support. For more information, visit